3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
20
Prostatic Neoplasms
11
Neoplasm Metastasis
9
Melanoma
8
Lung Neoplasms
8
Carcinoma, Renal Cell
8
Carcinoma, Non-Small-Cell Lung
8
Carcinoma, Hepatocellular
8
Kidney Neoplasms
7
Sarcoma
6
Liver Neoplasms
6
Triple Negative Breast Neoplasms
3
Thyroid Neoplasms
3
Small Cell Lung Carcinoma
3
Osteosarcoma
3
Desmoid Tumors
3
Carcinoma, Ductal, Breast
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Tongue Neoplasms
2
Pain
2
Keratosis, Actinic
2
Esophageal Neoplasms
2
Disease
2
Cholangiocarcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Neoplasms, Male
2
Wilms Tumor
1
Uveal Melanoma
1
Interventions
Colposcopy
13
Imiquimod
12
Conization
11
Papillomavirus Vaccines
8
Cryotherapy
6
Vaccines
5
Papanicolaou Test
4
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
Acetic Acid
4
Watchful Waiting
3
Vaginal Smears
3
Surveys and Questionnaires
3
Biopsy
3
human papillomavirus vaccine, L1 type 16, 18
2
Spectrometry, Fluorescence
2
Proflavine
2
Mass Screening
2
Immunohistochemistry
2
Human Papillomavirus DNA Tests
2
High-Throughput Screening Assays
2
Flow Cytometry
2
Curcumin
2
Blood Specimen Collection
2
pembrolizumab
1
nimotuzumab
1
lime
1
human papillomavirus vaccine, TA
1
hecolin
1
efineptakin alfa
1
Zoledronic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Cervical Dysplasia
×
Cryosurgery
×
Clear all
NCT00233727
2015-07-09
SAT
Columbia University
Phase 3
Terminated
7,123 enrolled